Studies on 4-allyloxy-3 chlorophenylacetic acid (Alcofenac). A double-blind comparison of Alcofenac and aspirin in rheumatoid arthritis, and effects of therapy on serum immunoglobulins and rheumatoid factor.
Open Access
- 1 May 1974
- journal article
- clinical trial
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 33 (3), 268-272
- https://doi.org/10.1136/ard.33.3.268
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Alclofenac in Rheumatoid Arthritis: an evaluation of its Anti‐inflammatory and Analgesic EffectsInternational Journal Of Clinical Practice, 1973
- Double-blind comparison of alclofenac and phenylbutazone in the short-term treatment of rheumatoid arthritisCurrent Medical Research and Opinion, 1973
- Effect of D-penicillamine on serum immunoglobulins and rheumatoid factor.Annals Of The Rheumatic Diseases, 1973
- A double-blind crossover trial comparing a new antirheumatic agent alclofenac with phenylbutazone in chronic rheumatic disorders.1972
- Toxicity studies of 4-allyloxy-3-chlorophenylacetic acid, a new analgesic, antipyretic, and anti-inflammatory agent.1970
- Pharmacology of a new analgesic, antipyretic, and anti-inflammatory agent, 4-allyloxy-3-chlorophenylacetic acid.1970
- 4-Allyloxy-3-chlorophenylacetic acid, a new type of analgesic, antipyretic and antiphlogistic drugThe Science of Nature, 1969
- Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis.1968
- Clinical measurement of the anti-inflammatory effects of salicylates in rheumatoid arthritis.BMJ, 1967
- DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association.1959